Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride improves hair growth.

NTF gel improves finasteride delivery for hair loss treatment, reducing side effects.

Green-synthesized nanoparticles can effectively target cancer cells, reducing side effects and improving treatment.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

Dutasteride-loaded nanoparticles coated with Lauric Acid-Chitosan show promise for treating hair loss due to their controlled release, low toxicity, and potential to stimulate hair growth.

Different hair loss types need accurate diagnosis for proper treatment.

Higher social status is linked to earlier diagnosis and better treatment results for Frontal Fibrosing Alopecia in women.

Hair dyes and perms can damage hair and scalp, but using interventions can reduce harm.

The cream effectively treats acne without causing irritation.

PRP shows promise for hair restoration with mild side effects, but more research is needed for clear guidelines.

Menopause-related skin changes may increase fungal infections and inflammation.

Skin diseases affect young adults in India physically and emotionally.

Polarized microscopy helps identify hair irregularities in genetic disorders.

Dandruff does not significantly affect androgenic alopecia.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Tailored nonsurgical cosmetic procedures are crucial for safely treating diverse skin types, especially skin of color.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

The guidelines recommend informed consent for gender-affirming treatments and stress the importance of personalized, culturally sensitive care for transgender individuals.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Removing the ATR gene in adult mice causes rapid aging and stem cell loss.

Certain mature cells in mouse lungs can turn back into stem cells to aid in tissue repair.

The guidelines suggest lifestyle changes, diet adjustments, and personalized medication to manage dyslipidemia and reduce heart disease risk.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

The Rotterdam Study updated findings on elderly health, focusing on heart disease, genetics, lifestyle effects, and disease understanding.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

Platelet-rich plasma can potentially promote hair growth by stimulating cell growth and increasing certain proteins.